Apart from cancer, mTOR inhibitors have also shown promising results in the treatment of genetic disorders such as tuberous sclerosis complex (TSC) and potential benefits in the treatment of neurodegenerative diseases such as Alzheimer’s disease [19]. This evidence concerns the gene MTOR and cancer.